These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1102 related items for PubMed ID: 24830595
1. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. Spritzer PM. Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595 [Abstract] [Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society. Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102 [Abstract] [Full Text] [Related]
3. Best methods for identification and treatment of PCOS. Artini PG, Di Berardino OM, Simi G, Papini F, Ruggiero M, Monteleone P, Cela V. Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113 [Abstract] [Full Text] [Related]
4. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Hum Reprod Update; 2015 Feb; 21(5):560-74. PubMed ID: 26060208 [Abstract] [Full Text] [Related]
5. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. Spritzer PM, Motta AB. Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303 [Abstract] [Full Text] [Related]
6. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Jeanes YM, Reeves S. Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828 [Abstract] [Full Text] [Related]
12. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls. Lanzo E, Monge M, Trent M. Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241 [Abstract] [Full Text] [Related]
13. Insulin-lowering agents in the management of polycystic ovary syndrome. De Leo V, la Marca A, Petraglia F. Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747 [Abstract] [Full Text] [Related]
17. Polycystic Ovary Syndrome in Adolescents. Witchel SF, Roumimper H, Oberfield S. Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968 [Abstract] [Full Text] [Related]
18. The latest reports and treatment methods on polycystic ovary syndrome. Stańczak NA, Grywalska E, Dudzińska E. Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663 [Abstract] [Full Text] [Related]
19. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Hum Reprod; 2004 Jan; 19(1):41-7. PubMed ID: 14688154 [Abstract] [Full Text] [Related]
20. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, Lin J, Zhu Y, Jiang Y, Feng HL, Qiao J. Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]